BRK-B vs DMA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
DMA exhibits severe financial weakness, highlighted by a Piotroski F-Score of 1/9, indicating critical failures in operational efficiency and financial health. The company reports 0.00% across all profit margins and lacks essential valuation data (Altman Z-Score, Graham Number), making it impossible to establish a fundamental floor. While the 17.13% dividend yield is superficially attractive, the 0% payout ratio and low dividend strength score (40/100) suggest a potential yield trap or return of capital. Technical trends are completely bearish (0/100), and recent price action shows a consistent short-term decline.
Compare Another Pair
Related Comparisons
BRK-B vs DMA: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Destra Multi-Alternative Fund (DMA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.